The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

Here’s how it works. mRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic. But more broadly, the technology could revolutionize many areas of medicine ...

Few medical advances in recent memory have sparked as much controversy as COVID-19 vaccines utilizing mRNA (messenger RNA). Currently, there are two such vaccines, from Pfizer-BioNTech and Moderna.

Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...

(Reuters) -Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after beginning ...

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. Cancer: it’s a diagnosis that most of us have learned to fear. On the one hand decades ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

Singling out Health Secretary Robert F. Kennedy Jr.’s worst decision is difficult, because the competition is fierce, but near the top of the list was his decision to terminate a series of federal ...